Cargando…
Loss of the collagen IV modifier prolyl 3-hydroxylase 2 causes thin basement membrane nephropathy
The glomerular filtration barrier (GFB) produces primary urine and is composed of a fenestrated endothelium, a glomerular basement membrane (GBM), podocytes, and a slit diaphragm. Impairment of the GFB leads to albuminuria and microhematuria. The GBM is generated via secreted proteins from both endo...
Autores principales: | Aypek, Hande, Krisp, Christoph, Lu, Shun, Liu, Shuya, Kylies, Dominik, Kretz, Oliver, Wu, Guochao, Moritz, Manuela, Amann, Kerstin, Benz, Kerstin, Tong, Ping, Hu, Zheng-mao, Alsulaiman, Sulaiman M., Khan, Arif O., Grohmann, Maik, Wagner, Timo, Müller-Deile, Janina, Schlüter, Hartmut, Puelles, Victor G., Bergmann, Carsten, Huber, Tobias B., Grahammer, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057608/ https://www.ncbi.nlm.nih.gov/pubmed/35499085 http://dx.doi.org/10.1172/JCI147253 |
Ejemplares similares
-
No benefit of HIF prolyl hydroxylase inhibition for hypertensive renal damage in renovascular hypertensive rats
por: Hartner, Andrea, et al.
Publicado: (2023) -
Studies on spiro[4.5]decanone prolyl hydroxylase domain inhibitors
por: Holt-Martyn, James P., et al.
Publicado: (2019) -
The role of HIF prolyl hydroxylases in tumour growth
por: Jokilehto, Terhi, et al.
Publicado: (2010) -
Function and expression of prolyl hydroxylase 3 in cancers
por: Liu, Qiu-long, et al.
Publicado: (2013) -
Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials
por: Yeh, Tzu-Lan, et al.
Publicado: (2017)